EUVIMEDEUVIMED entdecken
Crossref

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinoma

Tao Han, Ying Bai, Yafeng Liu, Yunjia Dong, Chao Liang, Lu Gao, Jiawei Zhou, Jianqiang Guo, Jing Wu, Dong Hu

Functional & Integrative Genomics · 2024-08 · 24 (4)

DOI: 10.1007/s10142-024-01388-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Functional & Integrative Genomics, online erschienen am 27.06.2024. Verfasst von Tao Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Immunotherapy, Machine Learning, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung adenocarcinoma (LUAD) has a malignant characteristic that is highly aggressive and prone to metastasis. There is still a lack of suitable biomarkers to facilitate the refinement of precision-based therapeutic regimens. We used a combination of 10 known clustering algorithms and the omics data from 4 dimensions to identify high-resolution molecular subtypes of LUAD. Subsequently, consensus machine learning-related prognostic signature (CMRS) was developed based on subtypes related genes and an integrated program framework containing 10 machine learning algorithms. The efficiency of CMRS was analyzed from the perspectives of tumor microenvironment, genomic landscape, immunotherapy, drug sensitivity, and single-cell analysis. In terms of results, through multi-omics clustering, we identified 2 comprehensive omics subtypes (CSs) in which CS1 patients had worse survival outcomes, higher aggressiveness, mRNAsi and mutation frequency. Subsequently, we developed CMRS based on 13 key genes up-regulated in CS1. The prognostic predictive efficiency of CMRS was superior to most established LUAD prognostic signatures. CMRS demonstrated a strong correlation with tumor microenvironmental feature variants and genomic instability generation. Regarding clinical performance, patients in the high CMRS group were more likely to benefit from immunotherapy, whereas low CMRS were more likely to benefit from chemotherapy and targeted drug therapy. In addition, we evaluated that drugs such as neratinib, oligomycin A, and others may be candidates for patients in the high CMRS group. Single-cell analysis revealed that CMRS-related genes were mainly expressed in epithelial cells. The novel molecular subtypes identified in this study based on multi-omics data could provide new insights into the stratified treatment of LUAD, while the development of CMRS could serve as a candidate indicator of the degree of benefit of precision therapy and immunotherapy for LUAD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungImmunotherapyMachine LearningLung NeoplasmsTumor MicroenvironmentHumansPrognosisBiomarkers, TumorGene Expression Regulation, NeoplasticGenomicsMultiomics

Stichwörter der Autor:innen

BioinformaticsDrug screeningImmunotherapyLung adenocarcinomaMachine learningMulti-omicsPrognosis

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China.
  • Anhui Occupational Health and Safety Engineering Laboratory, Huainan, Anhui, China.
  • School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China. by0319_cpu@163.com.
  • Anhui Occupational Health and Safety Engineering Laboratory, Huainan, Anhui, China. by0319_cpu@163.com.
  • School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, China. wujing8008@126.com.
  • Anhui Occupational Health and Safety Engineering Laboratory, Huainan, Anhui, China. wujing8008@126.com.

Zitieren

APA

Han, T., Bai, Y., Liu, Y., Dong, Y., Liang, C., Gao, L., Zhou, J., Guo, J., Wu, J., & Hu, D. (2024). Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinoma. Functional & Integrative Genomics, 24(4). https://doi.org/10.1007/s10142-024-01388-x

Vancouver

Han T, Bai Y, Liu Y, Dong Y, Liang C, Gao L, et al. Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinoma. Functional & Integrative Genomics. 2024;24(4). doi:10.1007/s10142-024-01388-x

BibTeX
@article{Han2024,
  author = {Han, Tao and Bai, Ying and Liu, Yafeng and Dong, Yunjia and Liang, Chao and Gao, Lu and Zhou, Jiawei and Guo, Jianqiang and Wu, Jing and Hu, Dong},
  title = {Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinoma},
  journal = {Functional & Integrative Genomics},
  year = {2024},
  volume = {24},
  number = {4},
  doi = {10.1007/s10142-024-01388-x}
}
Kostenlos starten →